Determination of Ebrotidine (cas 100981-43-9) and its metabolites by micellar electrokinetic capillary chromatography
-
Add time:08/15/2019 Source:sciencedirect.com
Ebrotidine (cas 100981-43-9) and its potential metabolites were determined by micellar electrokinetic capillary chromatography (MECC) using sodium dodecylsulfate (SDS) as surfactant. The influences of buffer composition, SDS concentration and addition of a neutral surfactant such as Brij 35 were studied. A 40 mM phosphate buffer at pH 7.50 containing 50 mM of SDS was selected as carrier electrolyte, and provided the optimum separation with regard to resolution and migration time. Linear calibration curves over the range studied (5.0–50 μg ml−1), limits of detection between 0.25 and 2.0 μg ml−1 and run-to-run precision lower than 10% were obtained. The MECC method was applied to the determination of these compounds in spiked human urine.
We also recommend Trading Suppliers and Manufacturers of Ebrotidine (cas 100981-43-9). Pls Click Website Link as below: cas 100981-43-9 suppliers
Prev:Original articleSynthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
Next:Acute liver injury associated with the use of Ebrotidine (cas 100981-43-9), a new H2-receptor antagonist) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of Ebrotidine (cas 100981-43-9) and its metabolites by capillary electrophoresis with UV and mass spectrometry detection08/24/2019
- General paperEffect of Ebrotidine (cas 100981-43-9) on the synthesis and secretion of gastric sulfomucin08/23/2019
- General paperInhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: Effect of Ebrotidine (cas 100981-43-9)08/22/2019
- General paperEnhancement in the protective qualities of gastric mucus by Ebrotidine (cas 100981-43-9) during duodenal ulcer healing08/21/2019
- Determination of Ebrotidine (cas 100981-43-9) and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography08/20/2019
- Ebrotidine (cas 100981-43-9) effect on the proteolytic and lipolytic activities of Helicobacter pylori08/19/2019
- General paperGastric mucosal laminin receptor expression with ulcer healing by Ebrotidine (cas 100981-43-9)08/18/2019
- General paperEnhancement of gastric mucus phospholipid secretion by an antiulcer agent, Ebrotidine (cas 100981-43-9)08/17/2019
- Acute liver injury associated with the use of Ebrotidine (cas 100981-43-9), a new H2-receptor antagonist08/16/2019


